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1. Introduction 
Coronary artery aneurysm (CAA) is a neglected topic in the pathology literature; most 
descriptions of CAAs have been limited to reports of single cases and some reviews. 
Because CAAs are usually found incidentally during cardiac examinations, most of the 
reported cases have been diagnosed by coronary angiography, intravascular ultrasound 
and, on rare occasions, during autopsy (Ramos et al., 2008). Although they are rare, CAAs 
can be potentially fatal if they are not managed in a judicious and timely manner.  
The first description of a CAA has been attributed to Morgagni, an Italian 
anatomopathologist of the mid-18th century. However, the first CAA in a living patient was 
diagnosed by coronary angiography (Munkner et al., 1958). Since then, many studies have 
been conducted on the pathology of abnormal dilatations of the coronary arteries; however, 
attempts at defining and classifying these abnormalities still create problems for researchers 
and physicians who work in this area. The major problem is differentiating between 
aneurysms and ectasias. Currently, CAA is defined as a localized, irreversible dilatation of 
the blood vessel lumen that exceeds the diameter of the adjacent normal segment by more 
than 1.5-fold (Falsett & Carrol, 1978; Swaye et al. 1983; Syed & Lesch, 1997). In contrast, 
ectasia is used to describe a diffuse dilatation of coronary arteries that involves 50% or more 
of the length of the artery; this classification is made according to the appearance and 
number of vessels involved (Markis et al, 1976). Ectasia has been subcategorized based on 
the topographical extent in the major epicardial coronary arteries into the following 4 types: 
type I, diffuse ectasia of two or three arteries; type II, diffuse ectasia in one artery and 
localized in another; type III, diffuse ectasia of one artery only; and type IV, localized and 
segmental ecstatic lesions (Markis et al., 1976). The existence of the last type causes 
confusion in separating aneurysms from ectasias; therefore, additional efforts to define 
specific anatomic substrates will help to standardize the reporting of this disease and 
minimize discrepancies in the literature regarding management. 
On rare occasions, a CAA grows large enough to be called a giant CAA, for which a precise 
definition is still lacking. Some authors consider coronary aneurysms to be giants when the 
CAA is greater than 2 cm (Mora et al., 2011), whereas the Committee of the American Heart 
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Association has defined giant aneurysms as those greater than 8 mm. In the literature, most 
of the reported maximum diameters of giant CAAs in adults have varied from 5 to 16 cm. 
Recently, cases of right giant CAAs have been recorded in MEDLINE and selected English-
language articles describing CAAs with diameters exceeding 5 cm over a 10–year period 
(1998-2008; Ramos et al., 2008). A male predilection (63%) and a mean age of 58 years were 
observed. The most frequent cause was atherosclerosis (37%), especially in older patients. 
The symptoms of the CAAs varied, and only four patients were asymptomatic. Surgical 
resection was the treatment of choice (74%), and most patients underwent coronary artery 
bypass grafting (59%) or coronary artery reconstruction (7%). The majority of the patients 
had an uneventful recovery. Only 7% (2/27) of the patients died from cardiac causes related 
to the CAA (Ramos et al., 2008).  
2. Incidence and anatomic distribution  
A wide variation exists in the incidence of CAA. This variation can be attributed to the 
conceptual differences in the definition of coronary aneurysms and ectasia. In the 
literature, the incidence of coronary artery disease has been predominantly in men with 
an average age of 63.5 years (Befeler et al., 1977; Daoud et al., 1983). In the order of 
frequency, the following are the most affected coronaries: right coronary artery (RCA; 
40.4%), left anterior descending artery (32.3%), left circumflex artery (23.4%), and rarely, 
left main coronary artery (3.5%); (Syed & Lesh, 1997). Atherosclerotic or inflammatory 
coronary aneurysms are usually multiple and involve more than one coronary artery. In 
contrast, congenital, traumatic, or dissecting aneurysms are usually single. Although 
coronary aneurysms are seen at any age, those related to atherosclerosis usually appear 
later in life than those associated with a congenital or inflammatory nature (Daoud et al., 
1983).  
3. Classification 
CAAs have been classified in different ways based on the composition of the vessel wall 
and the morphological structure (Table 1). Aneurysms are often classified by macroscopic 
shape and size, according to the transversal and longitudinal size. Saccular aneurysms are 
spherical and show a transverse diameter greater than the longitudinal diameter, whereas 
fusiform aneurysms are characterized by a gradual and progressive dilatation that 
involves the complete circumference of the artery and have a transverse diameter that is 
smaller than the longitudinal diameter (Williams & Stewart et al., 1994). Moreover, CAAs 
may be true or false (pseudoaneurysms) depending on the composition of the aneurysmal 
wall. True aneurysms contain all normal vascular layers, and the blood remains within 
the confines of the circulatory system. False, or pseudoaneurysms, are extravascular 
hematomas that communicate with the intravascular space. Normal vascular integrity is 
usually lost, resulting in the formation of thin-walled structures that lack normal arterial 
wall layers. Pseudoaneurysms typically occur after disruption of the external elastic 
membrane and frequently result from blunt chest trauma or catheter-based coronary 
interventions (Aqel et al., 2004). Furthermore, pseudoaneurysms usually affect only a 
portion of the artery wall and are more vulnerable to thrombosis and rupture (Williams & 
Stewart, 1994). 
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Classification of CAAs 
Characteristics  Categories  Luminal diameter of the aneurysm 
Shape  
Saccular 
Fusiform 
 
Maximum transverse diameter > longitudinal 
dimension 
Longitudinal dimension > maximum transverse 
diameter 
Vascular wall 
integrity 
 
True aneurysm 
Pseudoaneurysm 
 
All vascular layers present 
Loss of the vascular wall integrity 
Topographical 
extent 
 
Type I 
Type II 
Type III 
Type IV 
 
Diffuse dilatation of two or three vessels 
Diffuse dilatation in one vessel and localized in 
another 
Diffuse dilatation of one vessel only 
Localized or segmental dilatation 
Modified from Antoniadis et al., 2008; Díaz-Zamudio et al., 2009. 
Table 1. Morphologic and topographical classification of aneurysms and ectasias observed 
in coronary arteries. 
4. Epidemiology  
The prevalence of coronary artery disease in angiographic series has been documented to 
vary between 0.2 and 10%, but these studies have included both aneurysmal coronary 
disease and ectasias (Antoniadis et al., 2008). Because each angiographic diagnosis is 
operator-dependent, inter-observer variability may be responsible for the prevalence of 
discrepancies in different cohorts. Therefore, the documented frequencies may not represent 
the actual prevalence of coronary aneurysms in the general population. Moreover, one 
should not forget that a selection bias exists in patients referred for diagnostic coronary 
angiography. Table 2 shows exclusively the CAA prevalence in the most recent 
epidemiologic studies. 
Undoubtedly, important genetic and environmental influences affect incidence, and the 
CAA incidence has been shown to be lower in Asia than in North America and Europe. In 
contrast, a study of 302 patients with Kawasaki disease showed an incidence of coronary 
aneurysms of 10.3% in patients of Asian ethnicity compared with 6.9% in those of Caucasian 
ethnicity and 1.2% in those of African ethnicity (Porcella et al., 2005).   
Source  Diagnosis  Population  Prevalence (%) 
Falsetti & Carrol, 1976  Angiography  742  1.5 
Daoud et al., 1983  Autopsy  694  1.4 
Tunick et al.,1990  Angiography  8,422  0.2 
Wang et al., 1999  Angiography  10,120  0.1 
Harikrishnan et al., 2000  Angiography  3,200  0.7 
Groenke et al., 2005  Angiography  7,101  1.4 
Rozenberg & 
Nepomnyashchikh, 2005 
 Autopsy  
1,000 
 
 1.5 
Table 2. Prevalence of coronary artery aneurysms in angiographic and autopsy studies. 
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5. Etiology 
Coronary atherosclerosis and Kawasaki disease are the principal causes of CAAs. 
Atherosclerosis is the most common etiology in the U.S., and Kawasaki disease is the most 
common etiology in the Far East (Cohen & Ogara, 2008). Atherosclerosis is responsible for 
more than 50% of CAAs in adults in the Western world, whereas Kawasaki disease, which is 
characterized by an acute, self-limited vasculitis occurring in childhood, may lead to the 
development of CAAs in 15 to 25% of untreated children (Falsetti & Carrol, 1976; Pahlavan 
& Niroomand, 2006). Other causes of CAAs include inflammatory arterial diseases 
(polyarteritis nodosa, syphilis, Takayasu arteritis, Behçet´s disease), connective tissue 
disorders (systemic lupus erythematosus, rheumatoid arthritis, ankylosing spondylitis, 
scleroderma), hereditary collagen defects (Marfan syndrome, Ehlers-Danlos syndrome), 
coronary artery revascularization procedures (balloon angioplasty and laser atherectomy), 
candidiasis, chest traumas, and primary hyperaldosteronism (Alford et al., 1976; Antoniadis 
et al., 2008). CAA have also been noted in conjunction with infection, drug use, trauma, and 
percutaneous coronary intervention (Pahlavan & Niroomand, 2006). Therefore, many 
inflammatory disorders and infectious etiologies have been associated with CAAs. The 
etiologies usually vary according to the geographic location and age of the patient (Díaz-
Zamudio et al., 2009). 
 
Atherosclerosis 
Kawasaki disease 
Congenital 
Arteritis (polyarteriritis nodosa, syphilis, systemic lupus erythematous, Takayasu arteritis 
disease, Behçet´s disease)  
Mycotic 
Dissection 
Chest trauma 
Drugs 
Connective tissue disorders (SLE, rheumatoid arthritis, ankylosing spondylitis, 
scleroderma) 
Hereditary collagen defects (Marfan and Ehlers-Danlos syndromes) 
Metastatic tumor 
Coronary angioplasty (balloon, laser atherectomy, stent implantation, directional coronary 
atherectomy, pulsed laser coronary angioplasty and brachytherapy)* 
Modified from Syed & Lesch, 1997. SLE: systemic lupus erythematosus. *Mostly pseudoaneurysms. 
 
Table 3. Etiology of Coronary Artery Aneurysms. 
The following sections describe the primary causes of CAA. 
5.1 Atherosclerosis 
Atherosclerosis is the most common cause of morbidity and mortality worldwide. This 
disease is characterized by chronic inflammatory and intimal lesions, called atheromas or 
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fibrofatty plaques, which protrude into the lumen, weaken the underlying media and 
undergo a series of complications affecting primarily elastic arteries and larger and 
medium sized muscular arteries, such as coronary arteries (Libby, 2002). Dauod et al. 
(1963) believed that aneurysms are formed as a result of poststenotic transformation of 
kinetic energy to potential energy and pressure abnormalities in the vessel. Moreover, 
Siouffi et al. (1984) have explained that the elevated velocity of blood flow, which results 
in increased shear stress at the stenotic site, can promote endothelial injury and 
poststenotic vasodilation. In contrast, atherosclerotic plaque borders have been suggested 
to be potential foci of plaque disruption and thrombus formation, which cause 
microcirculation impairment and clinical symptoms of ischemia. The atherosclerotic mate-
rial located at the injured site presumably can act as the point of aneurysm formation 
(Berkoff & Rowe, 1975; Befeler et al., 1977). However, a theory from Markis et al. (1976) 
has suggested that the formation of the atherosclerotic aneurysm occurs as a result of an 
imbalance between the intravascular pressure and the elasticity of the vascular wall. In 
atherosclerosis, the vascular inflammation and plaques are distributed at near side 
branches or arterial stenosis (where blood flow is nonuniform) and at the lesser curvature 
of bends (where the blood flow rate is relatively low). Blood flow exerts shear stress on 
the vessel wall by altering cell physiology via several mechanisms. Shear stress also arises 
at the interplay between blood and the endothelial layer, where it induces a shearing 
deformation of the endothelial cells. Regions of the arterial tree with uniform geometry 
exert a physiologic shear stress, whereas arches and branches are exposed to a disturbed, 
oscillatory flow, which exerts low shear. Atherosclerotic lesions occur predominantly at 
sites of low shear, whereas regions of the vasculature exposed to a physiologic shear are 
protected (Koskinas et al, 2009). The occurrence of atherosclerotic lesions in the human 
carotid bifurcation, abdominal aorta and coronary artery strongly correlates with low 
shear regions experiencing an almost purely oscillatory flow (Moore et al., 1994). 
Atherosclerotic lesions are more frequent in the proximal portions of the three major 
coronary arteries (mainly the RCA). These data confirm that the coronary bifurcation 
pattern predisposes to the development of atherosclerotic lesions due to low endothelial 
shear stress. These atherosclerotic plaques develop in areas in which low endothelial 
shear stress occurs, inducing aneurysm formation as a result of endothelial damage 
(Chatzizisis et al., 2008). Inflammatory cells residing in the plaque (lymphocytes, 
macrophages, and foam cells) play an important role in the evolution and complication of 
atherosclerosis. These cells secrete cytokines that further amplify inflammation and 
produce proteases, such as metalloproteinase (MMPs) that destabilize the plaque by 
damaging the extracellular matrix (elastin) and thinning the fibrous cap (Libby, 2002). The 
result of elastin degradation is increased wall stiffness, elongation, and tortuosity of the 
vessel leading to areas of turbulent flow, which in combination with endothelial injury, 
favors the thrombus formation that is seen in most aneurysms (Hans et al., 2005). 
Microscopic evaluation of the atherosclerotic aneurysmal wall usually demonstrates 
typical components of atherosclerotic plaques, such as mononuclear cells infiltrates, lipid 
deposits, cholesterol crystals, destruction of the intima and media, diffuse hyalinization, 
focal fibrosis, calcification of the media, intramural hemorrhage and sometimes a foreign-
body giant cell reaction (Markis et al., 1976). A representative autopsy case is shown in the 
Figure 1. 
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Fig. 1. (A) Anterior view of the heart. Note a giant CAA (6x6.2x7.5 cm) starting after a 10-
mm-long segment of normal-sized RCA giving off the aorta and pushing back the right 
atrium. (B) Posterior view of the heart. The coronary aneurysm finishes as a 5-cm-long 
ecstasic arterial segment of the RCA along the atrioventricular groove to give off the 
posterior descending artery in the interventricular groove. In (A) and (B), the epicardium 
was removed to better show the diffuse atherosclerotic coronary artery disease (*). (C) 
Coronal section of the heart. The coronary aneurysm was empty and the wall was thickened 
with lipid deposits. Bar = 5cm. Microscopic section of the CAA wall. Note the dense 
fibrocollagenous thickening, extracellular lipids, mononuclear cells, and lymphocytic 
inflammatory infiltrates in the aneurysmal wall (D; Hematoxylin–eosin) and (E; Masson´s 
trichrome). Bar = 1mm. Ao: Aorta; CAA: coronary artery aneurysm; LA: left atrium; LV: left 
ventricle; PT: pulmonary trunk; RA: right atrium; RCA: right coronary artery, and RV: right 
ventricle. 
www.intechopen.com
 Coronary Artery Aneurysms: An Update 
 
387 
5.2 Coronary vasculitis 
Systemic vasculitis represents a large group of diseases that are defined as inflammatory 
lesions of blood vessels (Lightfoot et al., 1990). Inflammatory thickening of the coronary 
arteries may lead to their occlusion, weakness of the wall, and in some cases, the 
development of aneurysms.  
5.2.1 Kawasaki Disease (KD) 
KD or mucocutaneous lymph node syndrome, is the most common cause of CAA in 
children and the second most common in adults. KD is a multisystem inflammatory illness 
that predominately affects children 6 months to 5 years of age, although younger infants 
and older children can also develop the illness (Amano et al., 1979). KD can result in acute 
vasculitis, most strikingly of the coronary arteries (Newburger et al., 1986). Important 
complications include coronary artery dilation and aneurysm formation, which occurs in 
10–15% of patients during the acute stage. The incidence of KD is at least ten times higher in 
Japan than in Western populations (Nakamura et al., 2008). Siblings of children with KD 
have a tenfold higher risk of developing the illness than the general population, and 
children whose parents had KD have a twofold increased incidence (Uehara et al., 2003).  
The etiology of KD remains a major pediatric enigma, despite efforts to identify the cause 
over the last four decades. Many proposed etiologies of KD have been suggested since Dr. 
Tomisaku Kawasaki’s initial description of the illness in Japan in the 1960s (Kawasaki, 1967). 
The most widely proposed theories have fallen under the categories of environmental toxin 
exposure, autoimmune pathogenesis, and infectious diseases. Because the clinical and 
epidemiologic features of KD support an infectious cause, one speculation is that the 
infectious agent travels from its portal of entry through the bloodstream and infects many 
organs and tissues; the immune response then targets these sites of infection. The theory of 
KD etiology that best fits the available data is that a ubiquitous infectious agent results in 
asymptomatic infection in most individuals but causes KD in a subset of genetically 
predisposed individuals (Rowley et al., 2008). Up to 25% of untreated children will develop 
persistent abnormalities in the coronary arteries; however, therapy with intravenous 
gammaglobulin and aspirin within the first ten days of fever onset reduces the prevalence of 
coronary artery abnormalities to approximately 5% (Newburger et al., 1986). 
Inflamed tissues in acute KD show inflammatory cell infiltration of the arterial wall 
(mononuclear cells, lymphocytes, and macrophages), destruction of the internal elastic lamina, 
necrosis of smooth muscle cells, myointimal proliferation and subsequent occurrence of 
dilations or aneurysms (Burgner et al., 2009). Histopathological findings have indicated 
destruction of coronary artery walls with diffuse vasculitis, raising the possibility that MMPs 
are also involved in coronary arterial wall destruction and the formation of CAAs (Amano et 
al., 1979). Among patients with KD, those with coronary artery lesions have higher plasma 
levels of both MMP 3 and MMP 9. Within the arterial wall, the production of MMPs and other 
enzymes by macrophages results in the destruction of collagen and elastin fibers. The wall can 
lose its structural integrity and dilate or balloon, forming an aneurysm. The immune response 
is ultimately successful in controlling the pathogen, but damage to the coronary arteries may 
have already occurred (Yilmazet al., 2007). 
The diagnosis of KD is clinical and is based on the major clinical features of the acute phase. 
Undoubtedly, many asymptomatic adult patients with coronary arterial lesions caused by 
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KD remain undiagnosed, forming a hidden cohort with this disease (Tsuda et al., 2007). 
Even once acute KD was recognized, the diagnosis of complicating coronary artery lesions 
was more difficult in the sixties and seventies. Symptoms are rare in this population until 
the onset of acute coronary syndrome; consequently, the presence of coronary artery disease 
is unsuspected in most patients. Only recently have technical developments allowed the 
detailed examination of coronary artery morphology. 
Although the precise etiology and pathogenesis of KD are not completely understood, the 
current management of acute KD is based upon prospective, controlled, multicenter treatment 
trials that have clearly demonstrated the efficacy of intravenous immunoglobulin (IVIG) and 
high-dose aspirin to halt inflammation and reduce the likelihood of the development of 
coronary abnormalities when administered by the tenth day of illness (Newburger et al., 1991). 
Whether or not to continue antithrombotic therapy in patients with regressed giant aneurysms 
is an important problem to resolve in the future (Tsuda et al., 2010). 
5.2.2 Polyarteritis nodosa (PAN) 
For decades, most forms of vasculitis were termed periarteritis nodosa. Newly recognized 
types of this disease were characterized and classified according to features that were 
similar to or distinct from those of PAN (Klinger, 1931; Churg & Strauss, 1951). In the early 
1900s, Ferrari (1903) and Dickson (1908) proposed the name polyarteritis nodosa, partly to 
distinguish the disorder described by Kussmaul & Maier (1866) from the vascular lesion of 
tertiary syphilis. Furthermore, the term polyarteritis nodosa emphasizes the panarteritic 
nature of this disease and underscores the fact that multiple arteries are affected by the 
process (Arkin, 1930). PAN is one of a spectrum of diseases that belong to the pathologic 
category of necrotizing vasculitis. The classic form of PAN was described by Kussmaul & 
Maier in 1866 as consisting of focal panmural, necrotizing inflammatory lesions in small- 
and medium-sized arteries and characterized by fibrinoid necrosis and infiltration of 
predominantly polymorphonuclear leukocytes. PAN is a multiple organ disorder with 
characteristic involvement of the renal and other visceral arteries. Coronary artery 
involvement (76%) ranks second in frequency behind the renal arteries (85%) (Lypsky et al., 
1994). Thrombosis, aneurysms, and arteritis of the coronary vessels are known 
complications of the disease. PAN affects 2 to 6 people per 100,000 per year and can be seen 
in all ethnic groups. Any age group can be affected, but the disease occurs more commonly 
in men than in women (2:1) and is seen in people between the ages of 40 and 60 years. The 
cause of PAN is unknown for most patients. For years, an infectious etiology for PAN has 
been considered. Early observers considered streptococci or Staphylococcus aureus to be likely 
candidates (David et al., 1993). Hepatitis B surface antigenemia (with immune complex 
formation) has been reported to be associated with approximately 20% of patients with PAN 
(Trepo et al., 1974). The incidence is higher in areas where hepatitis B is endemic. In studies 
from France, the percentage of cases of PAN attributed to hepatitis B viral infection 
decreased from 36% to 7% during the past decade after the development of vaccines against 
viral hepatitis (Guillevin et al., 1996).  
Aneurysms often form at the branching points of small- and medium-sized arteries and 
occur in 9% of patients with PAN (Kastner et al., 2000). The rupture of aneurysms may 
result in spontaneous hemorrhage in approximately 6% of cases (Zizic et al., 1982). Acute 
lesions in PAN swiftly evolve into a panarteritis with degeneration of the arterial wall, 
destruction of the external and internal elastic lamina, and fibrinoid necrosis. The cellular 
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infiltrate is pleomorphic, with both polymorphonuclear cells and lymphocytes present to 
various degrees at different stages. Degranulation of neutrophils within and around the 
arterial wall leads to leukocytoclasis. In time, this inflammation leads to transmural necrosis 
and a homogeneous, eosinophilic appearance of the blood vessel wall (fibrinoid necrosis). 
The vascular wall inflammation in PAN may be strikingly segmental, affecting only part of 
the circumference of a given artery. Segmental necrosis, in turn, leads to aneurysm 
formation. During later stages, complete occlusion may occur secondary to endothelial 
proliferation and thrombosis. Throughout involved tissues, the coexistence of acute and 
healed lesions is typical. Features of granulomatous vasculitis are absent. Acute PAN 
evolves into a sclerotic process with fibrosis of the damaged arterial wall and mesenchymal 
organization. In some cases, there is also recanalization of thrombi. Chronic arterial 
narrowing may result (Stone, 2002). 
The identification of PAN can be a clinical challenge given its varied spectrum of organ 
involvement, wide range of clinical symptoms, and variations in severity. The clinical course 
can last from months to years, and relapse occurs in 40% of treated patients with a median 
interval of 33 months (Gordon et al., 1993). If untreated, the disease may have a fulminant 
course; the 5-year survival is less than 15%. However, survival increases to 80% with steroid 
treatment, with or without cytotoxic drugs (Guillevin et al., 1996). Symptoms, such as fever, 
malaise, and weight loss, are common, and up to 70% of patients have abdominal pain, 
nausea, vomiting, and infarction are uncommon, occurring in 1% of cases (Zizic et al., 1982). 
A combination of corticosteroids and immunosuppressants is a highly effective therapy for 
progressive PAN. Therefore, early diagnosis, which is usually based on clinical signs and 
symptoms and laboratory and angiographic findings, is crucial for the prognosis of the 
patient (Parangui et al., 1991). Arterial angiography is still an important measure in cases 
suggestive of PAN when other noninvasive tests do not allow diagnosis. The diagnosis of 
PAN is strongly indicated by the finding of aneurysms within the vasculature during 
angiography (Holzknecht et al., 1997). Early diagnosis and treatment of PAN are necessary 
to prevent serious organ damage and should be suspected in patients with febrile disease, 
weight loss, and evidence of multiple organ involvement. The diagnostic criteria have been 
classified by the American College of Rheumatology (Ewald et al., 1987). Three of 10 criteria 
must be present for the diagnosis of PAN, and positive angiography is one of the criteria. In 
symptomatic patients (with primarily abdominal complaints, nephropathy, hypertension, or 
generalized malaise), angiography is a valuable diagnostic tool that can lead to the diagnosis 
in occult cases. Angiographic findings, including aneurysms, ectasia, or occlusive disease, 
are present in approximately 40%–90% of patients at the time clinical symptoms appear 
(Hekali et al., 1991).  
Some case reports of coronary angiograms performed in patients with PAN have been 
published. Przybojewski (1981) has described a 29-year-old man for whom the coronary 
angiography revealed a diffusely aneurysmal RCA with severe obstructive lesions in the left 
circumflex and left anterior descending arteries. PAN was subsequently diagnosed by a 
skeletal muscle biopsy. The biopsy showed fibrinoid necrosis affecting connective tissue and 
blood vessels in the muscle epimysium and adjacent fascia, which are features that are 
characteristic of a collagen vascular disease such as PAN. Pick et al. (1982) have reported a 
26-year-old woman who, during cardiac catheterization, revealed numerous aneurysms 
involving all three coronary vessels that were particularly worse in the distal RCA. Cassling 
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et al. (1985) have described a 30-year-old female smoker who presented with intermittent 
chest pain and a strongly positive stress test. Coronary angiography revealed severe luminal 
narrowing of several coronary arteries without aneurysm formation. The clinical diagnosis 
was occlusive atherosclerotic coronary artery disease. The patient died intraoperatively after 
the anastomosis of coronary artery bypass grafts. Subsequent autopsy revealed an 
unexpected coronary adventitial thickening and a polymorphous lymphocytic infiltrate 
consistent with PAN. An autopsy case of PAN is shown in the Figure 2. 
For cases of idiopathic PAN, corticosteroids and cytotoxic agents remain the cornerstones of 
treatment (Guillevin et al., 1996). Approximately half of patients with PAN achieve remissions 
or cures with high doses of corticosteroids alone (Lam et al., 1981). Fortunately, the availability 
of effective antiviral agents has revolutionized the treatment of hepatitis B virus (HBV) 
infection-associated cases in recent years (Guillevin et al., 1996). Prophylactic treatment of 
large aneurysms by means of catheter embolization should be considered in anticipation of the 
risk of rupture. Aortography may not adequately substitute for selective injections of the 
viscera, but the retroperitoneal branches are depicted, and they can also be involved with 
aneurysms that may rupture in rare cases. In a small percentage of patients with PAN, 
aneurysm rupture in an organ or retroperitoneal branch may be the first clinical evidence of 
the disease. Embolization therapy is often the treatment of choice (Hachulla et al., 1993). The 
presence of aneurysms may relate to the phase of the disease or its severity. Arterial segments 
of ectasia may be either a precursor to a fully expanded aneurysm or a phase in the healing 
process. Aneurysms of PAN may resolve over time as remission occurs (Guillevin et al., 1996). 
 
Fig. 2. (A) Right posterolateral view of the heart of a 56-year-old woman with systemic PAN. 
Note the multiple aneurysms in coronary arterial tree. (B) Detail of aneurysmal nodules in 
the right marginal artery (arrows). Histopathology of the coronary artery (C), showing an 
important luminal occlusion by intimal proliferation, partial disruption of the internal 
elastic laminae and tunica media, intense inflammatory infiltrate and remarkable adventitial 
fibrotic thickening (C; Hematoxylin–eosin and D; Masson´s trichrome). Bar = 1mm. PAN: 
Polyarteritis Nodosa. 
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5.2.3 Takayasu arteritis 
Takayasu arteritis (TA) was first described in 1908 by the Japanese ophthalmologist Takayasu, 
who reported ocular changes, such as aneurysms and arteriovenous anastomoses, in patients 
with this disease. This primary systemic vasculitis is a group of autoimmune syndromes 
characterized by stenosis, occlusion, or aneurysmal dilation that involves the large cardiac 
vessels, chiefly the aorta and its main branches. Epidemiological data have demonstrated that 
TA is more common in Asian countries than in other parts of the world. The incidence of 
aneurysms in patients with TA has been reported to be approximately 18% and 24%, and 
approximately 150 new cases per year have been estimated in Japan. However, the disease 
may be found worldwide, including occidental countries (Subramanyan et al., 1989). TA 
primarily affects females, and the female to male ratio can reach up to 8:1 in adulthood (age 
≤40 yr); in childhood, the ratio is significantly lower at 2:1 (Sharma et al., 1996; Mesquita et al., 
1998). The etiology of TA remains unknown, although autoimmune mechanisms and 
infections are factors that have been reported to be associated with the disease. Genetic aspects 
also appear to contribute to the pathogenesis of TA (Buzaid et al., 1995).  
The clinical progression of TA can be divided into acute and chronic phases. The acute phase 
comprises signs and symptoms of a systemic inflammatory process, such as fever, weight loss, 
anorexia, fainting, dizziness, nocturnal sweating, myalgia, arthralgia/arthritis, exanthema, 
abdominal pain, vomiting and anemia. The chronic phase is characterized by symptomatology 
of vascular occlusion with the appearance of hypertension and changes in peripheral pulses 
(Morales et al., 1991). However, these phases are not always distinct and may occur 
simultaneously (Kerr, 1995). Most of the lesions cause luminal narrowing, which can lead to 
occlusion; however, coronary aneurysms are extremely rare. CAA can develop as vascular 
walls weaken because of arterial hypertension and the extensive destruction of elastic fibers in 
the media. CAA often cause stasis of blood flow and result in mural thrombus (Lie, 1998). The 
histological changes are characterized by marked thickening of the adventitia, media, and 
intima (Subramanyan et al., 1989). The inflammatory process involves the coronary arteries in 
less than 10% of patients, mostly in the form of stenotic lesions (Sharma et al., 1995), and can be 
divided into 3 distinct morphologic types: stenosis or occlusion of the coronary ostia, diffuse or 
focal coronary arteritis, and coronary aneurysm formation (Panja et al., 1998). Rarely, the 
inflamed aorta of TA can be a source of dissection, but the various symptoms and signs more 
commonly mimic an aortic dissection (Reichman & Weber, 2004). 
Diagnosis is difficult because the initial stage of the disease may be asymptomatic or may be 
characterized by the presence of signs and symptoms of the acute phase. The latter may lead to 
an erroneous diagnosis, such as rheumatic fever, juvenile rheumatoid arthritis or systemic 
lupus erythematosus (Kerr, 1995). Angiography and clinical examination remain the 
cornerstones for the diagnosis of TA. While arteriographic studies of the aortic and pulmonary 
territories are necessary to obtain a complete sense of the extent of the disease, these invasive 
techniques cannot be frequently repeated (Hata et al., 1996). Echocardiography has become a 
valuable noninvasive diagnostic technique for the detection of cardiovascular complications in 
patients with TA (Soto et al., 1996).The use of drug-eluting stents for the effective treatment of 
coronary lesions associated with TA (Kang et al., 2006). However, surgical treatment of TA 
poses many difficulties related to the timing of the operation, the techniques and materials 
used, and postoperative management. Even though TA is considered a severe disease, it rarely 
causes death (Kerr, 1995). Nevertheless, the outcome depends on the medical and surgical 
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treatment and on the cardiac involvement, severity, type of arterial hypertension and 
distribution of the vascular lesions (Mesquita et al., 1998). Currently, all treatment remains 
symptomatic because the etiology and pathogenesis of the disease are as yet unknown (Buzaid 
et al., 1985). Corticosteroids are the most widely employed drugs for the treatment of TA, and 
because they suppress the inflammatory manifestations and are helpful in the reversal of 
arterial stenosis, they are administered at high doses during the initial stage of the disease. 
Other drugs, such as cyclophosphamide, methotrexate and cyclosporin have been indicated 
for patients who do not respond to corticotherapy (Mesquita et al., 1998). An autopsy case is 
demonstrated in the Figure 3. 
 
Fig. 3. (A) Anterior and (B) posterior view of the heart, aorta and the major thoracic 
branches of a 17-year-old female diagnosed with Takayasu arteritis. Bar = 2.5cm. (C) Detail 
of the important luminal occlusion of the major thoracic arteries. (D) Histopathological view 
of the right carotid showing intimal thickening and partially recanalized thrombus. 
Hematoxylin-eosin; Bar = 1 mm. (E) RCA transversely sectioned to show the stenotic lumen. 
(F)  Histopathological view of the RCA showing intimal thickening, partially recanalized 
thrombus and prominent adventitial involvement. Hematoxylin-eosin; Bar = 1 mm. 
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5.3 Miscellaneous 
In addition to those described above, some other diseases are also involved in the formation 
of CAA. Connective tissue diseases, such as Marfan syndrome, can cause aneurysms 
without atherosclerosis. Marfan syndrome is associated with mutations in the gene for 
fibrillin that is homologous to the family of latent TGF-ǃ binding proteins, which hold TGF-
ǃ in an inactive complex (Gelb, 2006). Cystic medial degeneration is a common feature of the 
aneurysms in Marfan syndrome, so its presence in a CAA may be indicative of a congenital 
genetic defect that causes an excess of active TGF-ǃ. However, cystic medial degeneration is 
also commonly seen in the aortic aneurysms of late middle-aged and elderly patients 
without Marfan syndrome, but this degeneration could be indicative of excess active TGF-ǃ 
in these patients as well. TGF-ǃ can be inhibited by angiotensin II type 1–receptor 
antagonists, such as losartan, which can prevent aortic aneurysms in a mouse model of 
Marfan syndrome (Habashi et al., 2006).  
Systemic lupus erythematosus commonly causes arteritis, are rare and is most common in 
women of African descent who are of childbearing age (Matayoshi et al., 1999). Generally, 
these aneurysms are large and proximal and are in the setting of other obvious clinical 
markers of systemic disease. Clinical signs may include serositis, hematologic 
abnormalities, renal disease, dermatologic findings, abdominal angina, and neurologic 
findings, such as weakness, central nervous system vasculitis, and radiculopathy. In 
mycotic aneurysms, the injury and destruction of the tunica media may be due to 
microembolization to the vasa vasorum, direct pathogen invasion of the arterial wall, or 
immune complex deposition (Ford et al., 2007). Traumatic and iatrogenic aneurysms are 
frequently pseudoaneurysms. The pathogenesis of aneurysm formation after catheter-
based interventions is not fully understood (Bjorn-Hansen et al., 1989). This consequence 
has been attributed to the use of an oversized balloon, high inflation pressures, coronary 
dissection, interventions in the setting of acute myocardial infarction, and inadequate 
healing due to antiproliferative treatment with cortisone, colchicine, and anti-
inflammatory drugs (Vassanelli et al., 1989).  
Recently, with the advent of implantation of drug-eluting stents, increasing numbers of 
reports have suggested that stents can cause CAA months or years after the procedure 
(Pahlavan & Niroomand, 2006; Nichols et al., 2008). The drug-eluting stent contains an 
immunosuppressant, such as Sirolimus, which inhibits inflammation, or chemotherapeutic 
agents, such as Paclitaxel, which is an anti-inflammatory agent that inhibits cell 
proliferation. In due course, once the drug is eluted, the polymer in which the drug is 
embedded may elicit a hypersensitivity reaction and vasculitis and result in weakening of 
the vessel wall and subsequent dilatation (Manghat et al., 2006). Mechanical damage to the 
arterial wall during balloon angioplasty and stent placement or turbulent blood flow may be 
an added factor for the development of an aneurysm (Nichols et al., 2008). This concept is 
supported by the finding of an eosinophilic infiltrate in the few cases of such post-stent 
CAA that have been examined histologically (Virmani et al. 2004). Patients with a history of 
cocaine abuse have an increased prevalence of CAA (30.4%). These patients appear to be at 
increased risk of acute myocardial infarction. Several mechanisms have been proposed for 
the development of aneurysms related to cocaine abuse. These include (a) direct endothelial 
www.intechopen.com
 Novel Strategies in Ischemic Heart Disease 
 
394 
damage caused by severe episodic hypertension and vasoconstriction and (b) underlying 
atherosclerosis (Satran et al., 2005). 
6. Pathogenesis 
The pathogenesis of CAA is not completely understood but is likely to involve the 
destruction of the arterial media, thinning of the arterial wall, increased wall stress, and 
progressive dilatation of the coronary artery segment (Hirsch et al., 2000). Inflammation 
spilling over into the tunica media from the tunica intima has been hypothesized to link 
atherosclerosis to aneurysm formation in susceptible individuals. One could hypothesize 
that the giant cells that are sometimes present in CAA are merely reacting to cholesterol 
from atheroma and erythrocyte breakdown in the adjacent tunica intima. The 
lymphohistiocytic inflammation is merely spillover from the atherosclerosis in the adjacent 
tunica media. The cystic medial degeneration and aneurysm formation may be merely side 
effects of this spillover inflammation. Alternatively, one could hypothesize that the 
inflammation is sometimes due to autoimmune vasculitis coexisting with the atherosclerosis 
(Nichols et al., 2008).  
Aneurysm development can be a systemic or local disorder characterized by the 
overexpression of pro-inflammatory cytokines and enzymes that are capable of degrading 
elastin and other components of the vascular wall. The pathophysiology is focal 
destruction of the internal elastic lamina with early neutrophil infiltration followed by 
macrophages and cytotoxic T lymphocytes (Takahashi et al., 2005). Increased proteolysis 
of extracellular matrix proteins is probably a mechanism of CAA formation (Mata et al., 
2011). MMPs (1, 2, 3, 9 and 12) are capable of degrading essentially all components of the 
arterial wall matrix (elastin, collagen, proteoglycans, laminin, fibronectin, etc.) and are 
present at elevated concentrations in aneurysms, while decreased levels of tissue 
inhibitors of MMPs are present. The MMP-3, 5A allele is associated with higher promoter 
activity for transcription of the gene, and this allele is more common in patients with CAA 
plus atherosclerosis than patients with only coronary atherosclerosis (Lamblin et al., 
2005). CAAs have destruction of the tunica media, which is thinned, sometimes markedly, 
sometimes to the point of no longer being identifiable between the tunica intima and 
tunica adventitia. The normal smooth muscle cells and elastic fibers are replaced by 
hyalinized connective tissue. Destruction of the internal elastic lamina sometimes 
obscures the border between diseased tunica media and tunica intima diseased with 
atherosclerosis. Lipid deposits, foam cells, cholesterol clefts, eosinophilic debris, 
calcifications, neovascularization, inflammatory reactions, and sometimes hemorrhages 
can be seen and are sometimes limited to the tunica intima with atherosclerosis, 
sometimes extend into the tunica media and sometimes spread into the indistinct border 
zone. The inflammatory reaction chiefly consists of lymphocytes but can also include 
macrophages and sometimes foreign body giant cell formation around cholesterol clefts. 
Neutrophils, eosinophils, and plasma cells can be part of the inflammation. This 
inflammatory reaction is sometimes present in multiple arterial tunica and is sometimes 
transmural, involving all 3 layers of the artery. Thrombus formation is invariably present 
on the luminal surface of coronary aneurysms (Daoud et al., 1963). 
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Cause  Age  Description  Pathogenetic Mechanism 
Atherosclerosis  
Adults 
 
 
Most common cause of 
CAA, clinical importance 
depends on association 
with significant coronary 
artery stenosis 
 
Local mechanical stress from 
stenosis, atherosclerotic 
pathologic findings extending 
into tunica media 
Vasculitis 
Kawasaki 
disease 
 
 Childhood  
Most common cause of 
CAA in childhood in 
Japan, spontaneous 
resolution occurs in 50% 
 Autoimmune, vasculitis 
Takayasu  Young adults  
Common cause of CAA in 
young Asian females in 
Japan 
 
Cellular immunity associated 
with chronic infection 
Polyateritis Nodosa  Young adults  
Necrotizing inflammatory 
lesions in small- and 
medium-sized arteries 
 
Characterized by fibrinoid 
necrosis and infiltration by 
predominantly 
polymorphonuclear 
leukocytes 
Connective tissue 
disorders 
 
Young adults
 
 
Ehlers-Danlos syndrome, 
Marfan syndrome, cystic 
medial necrosis 
 
IL-6, TGF-ǃ, C-reactive 
protein, 
MMP-2, MMP-9 
Mycotic  Any age  
Infection with 
Staphylococcus 
aureus or Pseudomonas 
aeruginosa, 
syphilis, Lyme disease 
 
Microembolization to vasa 
vasorum, direct pathogen 
invasion of arterial wall, 
immune complex deposition 
Trauma/ 
iatrogenic 
 
 Adults  
Clinical history helps 
establish diagnosis healing 
because of 
antiproliferative treatment 
with cortisone, colchicine, 
and anti-inflammatory 
drugs 
 
Trauma from oversized 
balloon or high inflation 
pressures, coronary 
dissection, interventions in 
the setting of acute 
myocardial infarction, 
inadequate 
Modified from Diaz-Zamudio et al., 2009. 
Table 4. Cause, Age, Summary Description and Principal Pathogenetic Mechanisms of 
Coronary Artery Aneurysms 
7. Clinical manifestations and complications 
In most cases, CAAs are asymptomatic; then when symptomatic, the clinical manifestations 
depend on the underlying cause. Although CAA can be seen at any age, those that were 
related to atherosclerosis usually appear later in life than those of a congenital or 
inflammatory nature. 
No clinical feature characteristics exist for atherosclerotic CAAs. The clinical manifestations 
are similar to those seen in coronary artery disease (Tunick et al., 1990), and the patients 
may have angina pectoris, dyspnea, edema, myocardial infarction and sudden death (Pappy 
et al., 2011). Occasionally, a systolic murmur is heard over the precordium. An association 
with an abdominal aortic aneurysm and hypertension can occur. Large aneurysms, 
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particularly those that are partially or completely filled with mural thrombi, may create 
diagnostic challenges by masquerading as cardiac masses (Ramos et al., 2008). The main 
differential diagnoses include pericardial cysts and primary and metastatic tumors (Tunick 
et al., 1990). Transesophageal echocardiography and magnetic resonance imaging can add 
valuable diagnostic information; however, in many cases, diagnosis is not achieved until 
open-heart surgery. 
Factors that can contribute to development of complications are: distal embolization with 
myocardial ischemia, rupture with associated fistula, cardiac tamponade or 
hemopericardium, thrombosis, dissection, vasospasm and vessel compression (Syed & 
Lesch, 1997; Díaz-Zamudio et al., 2009). 
8. Diagnosis 
CAA may be detected by non-invasive tools, including echocardiography, computed 
tomography, and magnetic resonance imaging, but coronary angiography remains the best 
method for the assessment of coronary anatomy and pathology (Pahlavan & Niroomand, 
2006). Coronary angiography provides additional information regarding the size, shape, 
location and the number of existing anomalies and show an image of the coronary artery 
status (Gziut & Gil, 2008), determining the extent and severity of the coronary lumen 
obstruction in coronary artery disease (Scanlon et al., 1999). Multidetector row computed 
tomography (MDCT) technology, have led to widespread enthusiasm for the use of 
noninvasive coronary angiography (Hendel et al., 2006). The three dimensional evaluation 
helps to provide an easy understanding of complex anatomic structures and allows the 
analysis of the lumen and the vessel wall and the identification of thrombi and associated 
plaque formation. Other non-invasive methods can be also helpful in the diagnosis of 
aneurysms, including bidimensional transthoracic echocardiography, transesophageal 
echocardiography (Gziut & Gil, 2008) and electrocardiographic-gated scans, which is a dose 
modulation technique. These methods are recommended to minimize radiation dose and 
represent promising tools for the evaluation of children (Goz & Cakir, 2007), particularly 
children with Kawasaki disease (Beiser et al., 1998). Magnetic resonance (MR) angiography 
is an alternative for patients for whom exposure to repetitive radiation from multidetector 
CT is not wanted and for whom other noninvasive modalities are not suitable (Mavrogeni et 
al., 2004). However, these methods allow the investigation of only the proximal segments of 
the coronary arteries. Other modalities (such as intravascular ultrasound, Doppler flow 
wire, and pressure with for calculation of fractional flow reserve) can be incorporated into 
the invasive evaluation (e.g., angiography), and the pathology can often be treated during 
the same procedure. Multidetector-row computed tomography (MDCT), a technology that 
allows good noninvasive imaging of the coronary arteries, has been used despite of its 
indications and a still-to-be-defined role in the management of patients with cardiovascular 
symptoms (Zimmet & Miller., 2006). 
Undoubtedly, invasive coronary angiography remains the “gold standard” for the 
evaluation of CAA for a number of reasons. Only blood flow within the lumen can be 
evaluated, and conventional invasive coronary angiography provides no information about 
the vessel wall. Thus, with conventional coronary angiography, the true size of the 
aneurysm may be underestimated or the aneurysm may not even be seen when it is 
occluded or contains substantial thrombi or plaque (LaMotte & Mathur, 2000). 
www.intechopen.com
 Coronary Artery Aneurysms: An Update 
 
397 
9. Treatment 
CAA treatment consists of medical management, surgical resection, and stent placement; 
however, the appropriate treatment for CAAs is controversial and depends on the particular 
clinical situation. The recently available results have been based primarily on case reports 
and not on controlled studies, which continue to cause a therapeutic dilemma. The 
medically conservative therapy generally consists of attempts to prevent thromboembolic 
complications in patients with aneurysmal arteries who are at increased thrombotic risk 
through administration of antiplatelet and anticoagulant medication (Demopoulos et al., 
1997). The use of anticoagulants is based on the observations of thrombus formation in 
association with CAA and its distal embolization. Surgical management is appropriate in 
symptomatic patients who have obstructive coronary artery disease or evidence of 
embolization leading to myocardial ischemia and in patients with CAAs with a risk of 
rupture (LaMotte & Mathur, 2000). Recently, percutaneous application of 
polytetrafluoroethylene (PTFE)-covered stents has gained popularity due their ability to 
effectively limit the expansion of CAAs by reducing blood flow within the aneurysm, 
thereby preventing their rupture. Some authors have suggested that PTFE-covered stents 
should be limited to patients whose aneurysms are < 10 mm in diameter (Cohen & O’Gara, 
2008). Percutaneous strategies also include coil embolization, autologous saphenous vein-
covered stent grafting, and one case report of DES implantation superimposed on a PTFE-
covered stent graft (Ghanta et al., 2007). 
Surgical strategies that have been described include aneurysm ligation, resection, 
marsupialization with interposition graft, and coronary artery bypass surgery. The majority 
of the experience regarding the aforementioned strategies stem from atherosclerosis-
induced CAAs (Antelmi et al., 1993). Some surgeons believe that surgical repair is 
mandatory when a coronary aneurysm is 3 times larger than the original vessel diameter. A 
complete surgical resection or stent placement may be performed, depending on the 
presence or absence of coexisting obstructive coronary artery disease. Another surgical 
option that is frequently used is coronary artery bypass graft (CABG) followed by the 
ligation or resection of the aneurysm. This approach is indicated in patients who have larger 
aneurysms that are at higher risk of rupture (Myler et al., 1991).   
However, special consideration must be taken when an immunoinflammatory condition is 
involved. Treatment strategies to improve outcomes in vasculitis-induced CAA involve the 
use of immunosuppressive therapy to abate the underlying inflammatory process. The role 
of catheter-based intervention needs to be further explored in this particular patient 
population. It must be emphasized that there is no consensus regarding how coronary 
lesions related to systemic inflammatory diseases should be treated (Pappy et al., 2011). 
Currently, no treatment of CAAs has been universally accepted due to their low incidence 
and the lack of controlled clinical trials. 
10. Conclusion 
CAA is an uncommon and often accidental finding. CAAs are usually associated with 
atherosclerosis in adults in Western countries, while Kawasaki disease is the most common 
cause of CAA in Japan and in children or young adults. Nevertheless, the exact mechanisms 
leading to CAA formation are still unclear. Unfortunately, the lack of specific prodromal 
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symptoms or factors predisposing to the formation of CAAs significantly limits the 
diagnostic possibilities, and consequently, the therapeutic modalities. One way to improve 
the understanding of the pathogenesis of aneurysms can be through the development of 
experimental models, such as those that are used for studying abdominal aortic aneurysms 
(Mata et al., 2011). Thus, this review aimed to provide an update on the pathogenesis and 
treatment of CAAs to highlight for physicians and thoracic surgeons the practical 
management of patients with this disease and to help avoid major complications, such as 
death. 
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